DALTEPARIN News
DALTEPARIN currently has 0 news articles, with 9 predicted indications.
This page combines the AI-predicted indications for DALTEPARIN with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Evidence level: L5
- Predicted indications (9):
- acquired purpura fulminans (99.0%)
- purpura fulminans (99.0%)
- pulmonary embolism (disease) (99.0%)
- disseminated intravascular coagulation (99.0%)
- thrombophilia due to protein C deficiency, autosomal recessive (99.9%)
- primary release disorder of platelets (99.7%)
- pseudo-von Willebrand disease (99.5%)
- atypical hemolytic-uremic syndrome with thrombomodulin anomaly (99.3%)
- neuropathy, painful (99.2%)
Related News (0)
No related news yet. When news mentions this drug, it will be collected and shown here automatically.
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.